What makes promising pancreatic cancer drug different from chemotherapy?
Summary
A new drug for pancreatic cancer has been tested in medical trials. It helped patients live about twice as long compared to those who only had chemotherapy.Key Facts
- The drug targets pancreatic cancer specifically.
- Medical trials showed the drug extended patients’ survival time.
- Patients using the drug lived roughly twice as long as those on standard chemotherapy.
- Chemotherapy is the usual treatment for pancreatic cancer.
- The new drug works differently than chemotherapy.
- Dr. Jon LaPook reported on the results of these trials.
- The news was shared by CBS News.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.